SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-06-000842
Filing Date
2006-04-21
Accepted
2006-04-21 08:00:45
Documents
15
Period of Report
2006-06-09
Effectiveness Date
2006-04-21

Document Format Files

Seq Description Document Type Size
1 d18920.htm DEF 14A 488070
2 GRAPHIC baker.jpg GRAPHIC 14615
3 GRAPHIC brown-photo.jpg GRAPHIC 14810
4 GRAPHIC d18920line.jpg GRAPHIC 48287
5 GRAPHIC gilman.jpg GRAPHIC 14945
6 GRAPHIC goldstein.jpg GRAPHIC 14272
7 GRAPHIC proy-vagelos_sig.jpg GRAPHIC 3530
8 GRAPHIC regeneronlogo.jpg GRAPHIC 12579
9 GRAPHIC ryan-photo.jpg GRAPHIC 14138
10 GRAPHIC schleifer.jpg GRAPHIC 15035
11 GRAPHIC shooter.jpg GRAPHIC 15673
12 GRAPHIC sing.jpg GRAPHIC 14459
13 GRAPHIC stuart_kolinski-sig.jpg GRAPHIC 9164
14 GRAPHIC vagelos.jpg GRAPHIC 15080
15 GRAPHIC yancopoulos.jpg GRAPHIC 14565
  Complete submission text file 0001206774-06-000842.txt   796122
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 06771242
SIC: 2834 Pharmaceutical Preparations